UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

Annals of oncology, 2016-07, Vol.27 (7), p.1336-1341

2016

Volltextzugriff (PDF)

Identification of ovarian cancer patients for immunotherapy by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA)

Gynecologic oncology, 2018-06, Vol.149, p.36-36

2018

Volltextzugriff (PDF)

Anaplastic lymphoma kinase (ALK) aberrations in gynecologic cancers: New treatment options?

Gynecologic oncology, 2016-06, Vol.141, p.52-52

2016

Volltextzugriff (PDF)

Evaluation of genomic alterations by next generation sequencing provides a precision medicine-based approach for gynecologic cancers

Gynecologic oncology, 2017-06, Vol.145, p.83-84

2017

Volltextzugriff (PDF)

Use of next generation sequencing to predict response to primary chemotherapy in epithelial ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.91-91

2017

Volltextzugriff (PDF)

Comprehensive genomic profiling of rare gynecological malignancies

Gynecologic oncology, 2017-06, Vol.145, p.212-212

2017

Volltextzugriff (PDF)

Genomic alteration patterns and clinical actionability of comprehensive genomic profiling for the management of endometrial carcinoma

Gynecologic oncology, 2017-06, Vol.145, p.74-74

2017

Volltextzugriff (PDF)

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

Gynecologic oncology, 2016-10, Vol.143 (1), p.208-209

2016

Volltextzugriff (PDF)

Uterine Carcinosarcoma: Molecular Profiling and Identification of Possible Therapeutic Targets

Gynecologic oncology, 2016-10, Vol.143 (1), p.199-200

2016

Volltextzugriff (PDF)

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequentBAP1,PIK3CA, and other actionable genomic alterations

Annals of oncology, 2017-04, Vol.28 (4), p.748-753

2017

Volltextzugriff (PDF)

Analyzing biomarkers of cancer immunotherapy (CIT) response using a real-world clinico-genomic database

Annals of oncology, 2017-09, Vol.28, p.v404-v405

2017

Volltextzugriff (PDF)

Evaluation of the impact of comprehensive genomic profiling on clinical outcomes in gynecologic oncology patients

Gynecologic oncology, 2017-06, Vol.145, p.84-84

2017

Volltextzugriff (PDF)

Comprehensive genomic profiling of ovarian carcinomas identifies both ERBB2 amplifications and activating point mutations as biomarkers for anti-HER2 targeted therapy

Gynecologic oncology, 2016-06, Vol.141, p.176-176

2016

Volltextzugriff (PDF)

Comprehensive genomic profiling of ovarian clear cell carcinomas identifies clinically relevant genomic alterations and targeted therapy options

Gynecologic oncology, 2016-06, Vol.141, p.175-175

2016

Volltextzugriff (PDF)

2879 High prevalent BRAF alterations and tert promoter mutations in papillary thyroid carcinoma

European journal of cancer (1990), 2015-09, Vol.51, p.S583-S583

2015

Volltextzugriff (PDF)

319 Genomic profiling of uterine leiomyosarcomas reveal frequent alterations in Akt/mammalian target of rapamycin (mTOR) pathway genes and other actionable genomic abnormalities linked to targeted therapies

European journal of cancer (1990), 2014-11, Vol.50, p.104-104

2014

Volltextzugriff (PDF)

Response of mTOR inhibitor associated with mutation of FBXW7 gene identified by comprehensive genomic profiling in cervical squamous cell carcinoma supports additional therapy opportunity for select patients with treatment-refractory, recurrent disease

Gynecologic oncology, 2020-10, Vol.159, p.166-167

2020

Volltextzugriff (PDF)

Matched sequential tumor molecular profiling in solid malignancies may impact clinical practice

Gynecologic oncology, 2020-10, Vol.159, p.263-264

2020

Volltextzugriff (PDF)

Genomic profiling of mesonephric and mesonephric-like carcinomas via solid and liquid biopsy reveals driver mutations and opportunities for targeted therapies

Gynecologic oncology, 2020-10, Vol.159, p.198-199

2020

Volltextzugriff (PDF)

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Annals of oncology, 2017-10, Vol.28 (10), p.2539-2546

2017

Volltextzugriff (PDF)

Comprehensive genomic profiling (CGP) of uterine adenosarcomas (uAS) suggests novel therapeutic approaches

Gynecologic oncology, 2018-06, Vol.149, p.237-237

2018

Volltextzugriff (PDF)

Mutation profiles of paired ovarian cancers across time

Gynecologic oncology, 2019-06, Vol.154, p.49-50

2019

Volltextzugriff (PDF)

Molecular driven endometrial cancer therapy (MODEL): A prospective paradigm using molecular tumor profiling to direct therapy in women with advanced/recurrent endometrial cancer

Gynecologic oncology, 2019-06, Vol.154, p.248-248

2019

Volltextzugriff (PDF)

Impact of clinical and genomic factors on outcomes for pancreatic adeoncarcinoma based on race

HPB (Oxford, England), 2023, Vol.25, p.S95-S95

2023

Volltextzugriff (PDF)

Comprehensive genomic characterization of small cell neuro-endocrine carcinoma of the cervix

Gynecologic oncology, 2018-06, Vol.149, p.187-187

2018

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(15)
Obstetrics And Gynecology
(12)
Life Sciences & Biomedicine
(5)
Oncology
(5)
Science & Technology
(5)
Humans
(3)
Aged
(2)
Female
(2)
Genomic Alteration
(2)
Head And Neck Cancer
(2)
Hiv
(2)
Human Immunodeficiency Virus
(2)
Immunology
(2)
Infectious Diseases
(2)
Male
(2)
Middle Aged
(2)
Pi3k
(2)
Salivary Gland Cancer
(2)
Acquired Immune Deficiency Syndrome
(1)
Adult
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

Identification of ovarian cancer patients for immunotherapy by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA)

Anaplastic lymphoma kinase (ALK) aberrations in gynecologic cancers: New treatment options?

Evaluation of genomic alterations by next generation sequencing provides a precision medicine-based approach for gynecologic cancers

Use of next generation sequencing to predict response to primary chemotherapy in epithelial ovarian cancer

Comprehensive genomic profiling of rare gynecological malignancies

Genomic alteration patterns and clinical actionability of comprehensive genomic profiling for the management of endometrial carcinoma

Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies

Uterine Carcinosarcoma: Molecular Profiling and Identification of Possible Therapeutic Targets

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequentBAP1,PIK3CA, and other actionable genomic alterations

Analyzing biomarkers of cancer immunotherapy (CIT) response using a real-world clinico-genomic database

Evaluation of the impact of comprehensive genomic profiling on clinical outcomes in gynecologic oncology patients

Comprehensive genomic profiling of ovarian carcinomas identifies both ERBB2 amplifications and activating point mutations as biomarkers for anti-HER2 targeted therapy

Comprehensive genomic profiling of ovarian clear cell carcinomas identifies clinically relevant genomic alterations and targeted therapy options

2879 High prevalent BRAF alterations and tert promoter mutations in papillary thyroid carcinoma

319 Genomic profiling of uterine leiomyosarcomas reveal frequent alterations in Akt/mammalian target of rapamycin (mTOR) pathway genes and other actionable genomic abnormalities linked to targeted therapies

Response of mTOR inhibitor associated with mutation of FBXW7 gene identified by comprehensive genomic profiling in cervical squamous cell carcinoma supports additional therapy opportunity for select patients with treatment-refractory, recurrent disease

Matched sequential tumor molecular profiling in solid malignancies may impact clinical practice

Genomic profiling of mesonephric and mesonephric-like carcinomas via solid and liquid biopsy reveals driver mutations and opportunities for targeted therapies

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

Comprehensive genomic profiling (CGP) of uterine adenosarcomas (uAS) suggests novel therapeutic approaches

Mutation profiles of paired ovarian cancers across time

Molecular driven endometrial cancer therapy (MODEL): A prospective paradigm using molecular tumor profiling to direct therapy in women with advanced/recurrent endometrial cancer

Impact of clinical and genomic factors on outcomes for pancreatic adeoncarcinoma based on race

Comprehensive genomic characterization of small cell neuro-endocrine carcinoma of the cervix

Suchergebnisse filtern